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As an undesirable side effect,
sildenafil citrate (Viagra) partially
inhibits the phosphodiesterase
PDE6 [1], which plays an essential
role in phototransduction
(reviewed in [2,3]). PDE6 not only
activates the visual transduction
cascade, but also controls the
time over which the visual
response is integrated, thereby
helping to maintain the size of the
visual response within an optimal
range as the light level is
increased [4]. Consistent with an
increase in temporal integration
following Viagra ingestion,
performance improvements have
been reported for an identification
task that relies on the integration
of two temporally separated
stimuli [5]. Using more
conventional psychophysical
measures of temporal sensitivity
and resolution [6,7], we find that
therapeutic 100 mg doses of
Viagra can cause mild to
moderate transient losses in
human temporal visual sensitivity.
These losses imply that in the
more affected observers, Viagra
may provide a unique tool for
pharmacologically manipulating
the activity of PDE6 in humans in
vivo, and thus for investigating the
role of PDE6 in light adaptation. At
the light levels tested, the
frequency-dependent sensitivity
losses caused by the inhibition of
PDE6 by Viagra are consistent
with an almost doubling of the
time over which visual events are
normally integrated (from ~6.9 to
12.6 ms, assuming a single
integration stage).
Observers were presented with
a flickering red (650 nm) target
superimposed in the centre of a
moderate-intensity blue (481 nm)
background field. They were
asked to set the highest temporal
frequency at which the flicker
appeared to be just visible — alsoFigure 1. Critical flicker fusion (A,B) and modulation sensitivity (C,D) data for L.T.S.
(A,C) and G.J. (B,D).
A centrally fixated flickering target of 4° of visual angle in diameter and 650 nm in wave-
length was presented in the centre of a 9° background field of 481 nm. The background
of 8.26 log quanta s–1 deg–2 at the cornea was there primarily to saturate the rods. The
mean radiance of the 650 nm target was varied for the c.f.f. measurements and fixed at
9.52 log quanta s–1 deg–2 for the modulation sensitivity measurements. In each panel,
the pre-Viagra baseline data (dotted open circles) are the averages of three or more
separate measurements made before drug ingestion. The shapes of the coloured
symbols denote the dose numbers: dose 1 (triangles); dose 2 (circles); dose 3 (inverted
triangles); and dose 4 (hexagons). The time after dose ingestion is coded by the colour
of the symbols (see key). The times noted are the midpoints of the time periods after
dose ingestion during which a given curve was measured (from the first setting made
at the end of a 3 min pre-adaptation period to the last setting). A c.f.f. curve required on
average 12 min to complete, whereas a modulation sensitivity curve required 8 min.
Crossed symbols distinguish between two runs made during the same colour-coded
time window. 
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Current Biologyknown as the temporal resolution
limit or critical fusion frequency
(c.f.f.) — as a function of the
radiance of the 650 nm target.
Under these conditions of
adaptation, flicker detection is
mediated by long-wavelength
sensitive (L–) cones, and to a
lesser extent by middle-
wavelength sensitive cones (M–)
cones. The results are shown in
Figure 1 for observers L.T.S. (A)
and G.J. (B). With increasing
target radiance, their baseline
(pre-Viagra) c.f.f. functions (open
dotted circles) rise steadily until
reaching a plateau between 38
and 52 Hz. Ingestion of Viagra
induces moderate losses in c.f.f.
for both subjects at all levels.Below the plateau, the losses
increase slightly with target
radiance, reaching ~10 Hz for
L.T.S. and 5 Hz for G.J. (coloured
symbols).
To characterize the losses at
frequencies below the c.f.f., we
measured modulation thresholds
as a function of temporal
frequency. Subjects were asked
to adjust the target modulation
until the apparent flicker was just
visible. Modulation is adjusted by
varying the fraction of the light
that flickers, while keeping the
time-average intensity of the light
constant. Figure 1 shows
temporal modulation sensitivities
for L.T.S. (C) and G.J. (D)
measured at a 650 nm radiance
Magazine
R45of 9.52 log quanta s–1 deg–2
(Figure 1, vertical dashed lines).
Consistent with the changes in
their c.f.f. data, both L.T.S. and
G.J. show some losses of
modulation sensitivity after
ingesting Viagra at most
frequencies. The relative losses
compared with baseline are
highlighted in Figure 2 for LTS (A)
and GJ (B) for data collected
between 60 and 166 min after
Viagra ingestion, in which it
becomes clear that the losses for
both subjects increase with
temporal frequency. This
steepening suggests that Viagra
is associated with a lengthening
of the visual integration time.
We can model the mean losses
(continuous lines in Figure 2A,B
and symbols in 2C) and thus
obtain a rough estimate of the
change in the time constant of
integration by assuming that the
Figure 2. Modulation sensitivity losses
for L.T.S. (A) and G.J. (B).
The data, from Figure 1, are plotted rela-
tive to the mean baseline measurements
(horizontal lines). Symbol and symbol
colours are as in Figure 1. The continu-
ous lines are the mean losses, plotted in
(C) for L.T.S. (dotted circles) and G.J.
(grey dotted squares), which also shows
the model fit (red line).
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Current Biologychange occurs at a single
integrating stage with an
exponential decay (which we
assume reflects the activity of
some biochemical process or
processes, such as the
hydrolysis of cGMP catalyzed by
PDE6). We model this change by
applying a standard equation for
a leaky integrator [8] and
determining the change in
integration time that will best
account for our data (see
Supplemental Data available on-
line). Given that the mean data
for L.T.S. (dotted circles) and G.J.
(grey dotted squares) are similar,
we have fitted this model
simultaneously to both mean
data sets. The model has three
parameters: a baseline
integration time, a Viagra-
induced integration time and a
frequency-independent
sensitivity scaling factor.
The best-fitting model is shown
by the continuous red line in the
lower panel. The best-fitting
parameters (± the asymptotic
standard error for each
parameter) are 6.91(±2.64) ms for
the baseline integration time,
12.57(±3.79) ms for the Viagra-
induced integration time, and
0.34(±0.05) log10 unit for the
scaling factor. The scaling factor
is needed to compensate for
changes in sensitivity caused by
the background becoming more
effective when the integration
time is lengthened (by 0.26 log10
unit for a 6.91–12.57 ms change
in time constant). This increase in
effectiveness is partially offset by
the comparable increase in
sensitivity to low frequency
flicker, but not entirely so (a
complete offset would be
consistent with Weber’s Law).
The fact that the overall
modulation sensitivity drops by
0.08 log10 represents a partial
failure of light adaptation as
Viagra presumably drives the
system into a less optimal
(nonlinear) part of its operating
range. The data are clearly
consistent with a lengthening of
the integration time, but the
precise values of the time
constants are only moderately
well constrained by the model,
and should be considered as
preliminary estimates.By inhibiting PDE6, Viagra
lengthens the time over which the
visual response is integrated,
thus impairing the overall ability
of the eye to light adapt and to
regulate its sensitivity.
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